Table 4.
First Author, Year | Sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting |
---|---|---|---|---|---|---|
Bakkum 201542 | Low | Low | High | Low | High | Low |
de Abreu 200650 | High | High | High | Unclear | Low | Low |
de Abreu 200852 | High | High | High | Unclear | Low | Unclear |
de Abreu 200951 | High | High | High | Unclear | Low | High |
Giangregorio 201237 | Low | Low | High | Low | Low | Low |
Gorgey 201239 | Low | Unclear | High | Unclear | Low | Low |
Gorgey 201338 | Low | Unclear | High | Unclear | Low | Low |
Kim 201545 | Low | Low | High | Unclear | Low | Low |
Ordonez 201343 | Unclear | Low | High | Unclear | Unclear | High |
Rosety-Rodriguez 201444 | Unclear | Low | High | Unclear | Unclear | Low |
Totosy de Zepetnek 201540 | Low | Low | High | Unclear | Low | Low |
Note: EMD = Endocrine-metabolic disease; SCI = Spinal cord injury.